drug · small molecule
brexanolone
Marketedupdated 3mo agoby $LPCN Lipocine Inc.🔗 ChEMBL
Approvedcommunity read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 3 approved and 10 investigational indications.
indications
investigational
Alzheimer's Disease
targets
GABA-A receptor; anion channel
all catalysts(0)
nothing on the calendar yet
Trials studying brexanolone
- phase1Utility of Brexanolone to Target Stress-induced Alcohol Use Among Men and Women With Posttraumatic Stress Disorder
- phase3A Study to Assess the Safety of Brexanolone in the Treatment of Adolescent Female Participants With Postpartum Depression (PPD)
- —Expanded Access Protocol of ZULRESSO™ (Brexanolone) Injection for Adult Patients With Postpartum Depression
- phase2An Open-Label Study Evaluating Brexanolone in Adults With Tinnitus
- phase2Brexanolone to Target Concurrent PTSD and Stress Induced Alcohol Use in Veterans: A Dose Finding Study
- —Dynamic Neural Mechanisms of Brexanolone-induced Antidepressant Effects in Postpartum Depression
- EP1Effects Zulresso on Postpartum Psychosis
- phase4An Open Label Pilot Study of IV Brexanolone for the Treatment of Post-Traumatic Stress Disorder
Patent cliff
source: FDA Orange Bookfirst barrier falls
Mar 13, 2029
~2.6 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (8)
- Mar 8, 2037method-of-use (U-2552)US 10940156
- Nov 27, 2033method-of-use (U-2552)US 10251894
- Jan 23, 2033formulationUS 10322139
- Mar 13, 2029formulationUS 101179512.6y
- Mar 13, 2029formulationUS 76357732.6y
- Mar 13, 2029formulationUS 84100772.6y
- Mar 13, 2029formulationUS 92000882.6y
- Mar 13, 2029formulationUS 97508222.6y
News(1)
- Two biotechs raise a combined $556M in latest spurt of IPOsSeaport Therapeutics and Hemab Therapeutics on Thursday became the latest drugmakers to debut on Wall Street, continuing a stretch of large IPOs this year that collectively raised almost $3.2 billion.biopharma_dive · 3mo ago
Data sources
last refreshed 5m ago
Found something off?
comments(0)
5-min edit window · permanent after that